» Articles » PMID: 38928308

Exosomes Derived from Adipose Mesenchymal Stem Cells Promote Regeneration of Injured Liver in Minipigs

Overview
Journal Int J Mol Sci
Publisher MDPI
Date 2024 Jun 27
PMID 38928308
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatic ischemia/reperfusion injury (IRI) is an important factor affecting liver regeneration and functional recovery postoperatively. Many studies have suggested that mesenchymal stem cells (MSCs) contribute to hepatic tissue repair and functional recovery through paracrine mechanisms mediated by exosomes. Minipigs exhibit much more similar characteristics of the liver to those of humans than rodents. This study aimed to explore whether exosomes from adipose-derived MSCs (ADSCs-exo) could actively promote liver regeneration after hepatectomy combined with HIRI in minipigs and the role they play in the cell proliferation process. This study also compared the effects and differences in the role of ADSCs and ADSCs-exo in the inflammatory response and liver regeneration. The results showed that ADSCs-exo suppressed histopathological changes and reduced inflammatory infiltration in the liver; significantly decreased levels of ALT, TBIL, HA, and the pro-inflammatory cytokines TNF-α, IL-6, and CRP; increased levels of the anti-inflammatory cytokine IL-10 and the pro-regeneration factors Ki67, PCNA, CyclinD1, HGF, STAT3, VEGF, ANG1, ANG2; and decreased levels of the anti-regeneration factors SOCS3 and TGF-β. These indicators above showed similar changes with the ADSCs intervention group. Indicating that ADSCs-exo can exert the same role as ADSCs in regulating inflammatory responses and promoting liver regeneration. Our findings provide experimental evidence for the possibility that ADSCs-exo could be considered a safe and effective cell-free therapy to promote regeneration of injured livers.

Citing Articles

Mesenchymal Stem Cell-Derived Exosomes: Emerging as a Promising Cell-Free Therapeutic Strategy for Autoimmune Hepatitis.

Wu L, Zhang L, Huang M, Wu Y, Jin S, Zhang Y Biomolecules. 2024; 14(11).

PMID: 39595530 PMC: 11592114. DOI: 10.3390/biom14111353.


Therapeutic Potential of Stem Cell-Derived Extracellular Vesicles in Liver Injury.

Dong J, Luo Y, Gao Y Biomedicines. 2024; 12(11).

PMID: 39595055 PMC: 11591663. DOI: 10.3390/biomedicines12112489.

References
1.
Kim Y . Ischemia-reperfusion injury of the human liver during hepatic resection. J Hepatobiliary Pancreat Surg. 2003; 10(3):195-9. DOI: 10.1007/s00534-002-0730-x. View

2.
Li J, Jing Y, Bai F, Wu Y, Wang L, Yan Y . Induced pluripotent stem cells as natural biofactories for exosomes carrying miR-199b-5p in the treatment of spinal cord injury. Front Pharmacol. 2023; 13:1078761. PMC: 9871459. DOI: 10.3389/fphar.2022.1078761. View

3.
Wang S, Liu Z, Yang S, Huo N, Qiao B, Zhang T . Extracellular vesicles secreted by human gingival mesenchymal stem cells promote bone regeneration in rat femoral bone defects. Front Bioeng Biotechnol. 2023; 11:1098172. PMC: 9989199. DOI: 10.3389/fbioe.2023.1098172. View

4.
Anger F, Camara M, Ellinger E, Germer C, Schlegel N, Otto C . Human Mesenchymal Stromal Cell-Derived Extracellular Vesicles Improve Liver Regeneration After Ischemia Reperfusion Injury in Mice. Stem Cells Dev. 2019; 28(21):1451-1462. DOI: 10.1089/scd.2019.0085. View

5.
Cottart C, Do L, Blanc M, Vaubourdolle M, Descamps G, Durand D . Hepatoprotective effect of endogenous nitric oxide during ischemia-reperfusion in the rat. Hepatology. 1999; 29(3):809-13. DOI: 10.1002/hep.510290317. View